Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07421544 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 19, 2026 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Clinical trial to assess the real-world effectiveness of Obagi® Saypha® MagIQ™ Injectable Hyaluronic Acid (HA) gel for the treatment of mild-to-moderate facial aging, including volume loss, fine lines, and skin laxity, following treatment administered using routine clinical injection techniques over the course of 60 days.
Trial Details
NCT Number NCT07421544
Lead Sponsor Goldman, Butterwick, Fitzpatrick and Groff
Collaborators: Obagi
Conditions
(from sponsor)		 Fine Lines, Wrinkle, Facial Laxity, Volume Loss
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov